T- and B-cellular immunity system in thyrotoxicosis patients treated with thyrostatic preparations
Kabatsiĭ, N.P.
Vrachebnoe Delo 2: 80-82
1984
ISSN/ISBN: 0049-6804 PMID: 6202062 Document Number: 241315
Document emailed within 1 workday
Related Documents
Shishiba, Y. 1978: Abnormality and deficiency in cellular immunity and internal diseases--Basedow's disease and cellular immunity Nihon Rinsho. Japanese Journal of Clinical Medicine 36(5): 960-966Allannic, H.; Genetet, N.; Edan, G.; Merdrignac, G.; Simon, M.; Genetet, B. 1987: Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis Pathologie-Biologie 35(10): 1333-1338
Nagura, Y. 1975: Cellular immunity and antibody production system in systemic lupus erythematosus Nihon Jinzo Gakkai Shi 17(2): 103-120
Kuznetsov, V.A.; Zhivoglyadov, V.P.; Stepanova, L.A. 1993: Kinetic approach and estimation of the parameters of cellular interaction between the immunity system and a tumor Archivum Immunologiae et Therapiae Experimentalis 41(1): 21-31
Lakiza, V.V. 1972: Sodium and potassium concentration in patients treated for thyrotoxicosis Klinicheskaia Khirurgiia 9: 73-76
Torgyán, S. 1971: Immunoserological studies in patients with thyrotoxicosis treated with radioiodine Therapia Hungarica 19(3): 92-96
Mikolauskas, V.P. 2004: Cellular immunity in patients with urogenital chlamydiosis Klinicheskaia Laboratornaia Diagnostika 4: 36-38
Atanadze, S.N.; Kodkind, G.K.; Smirnov YuK; Khomak, V.I.; Veĭn, A.M. 1980: Measles cellular immunity in patients with multiple sclerosis Voprosy Virusologii 2: 166-169
Spengler, H.; Brunner, K.W.; de Weck, A. 1972: Longitudinal studies on cellular immunity in patients with neoplasms Schweizerische Medizinische Wochenschrift 102(33): 1167-1169
Nagai, T.; Kondo, A.; Yoshida, N.; Atomachi, Y. 1975: Mechanism in reduced cellular immunity in cancer patients Hokkaido Journal of Medical Science 50(1): 85-86
Dziuba, A.N.; Frolov, V.M.; Gaĭdash, I.S. 1992: Indicators of cellular immunity in patients with multiple sclerosis Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 92(2): 12-14
Auer, I.O.; Ziemer, E.; Sommer, H.; Malchow, H.; Ehms, H. 1977: Status of cellular immunity in patients with Crohn's disease Verhandlungen der Deutschen Gesellschaft für Innere Medizin 83: 841-844
Ma, Z.; Chen, P.; Hou, X. 1999: Effect of cefodizime on cellular immunity in patients with lung cancer Zhonghua Zhong Liu Za Zhi 21(3): 190-192
Selroos, O.; Nikinmaa, B.; Koivunen, E.; Riska, H.; Tiitinen, H.; Weber, T. 1982: Cellular immunity during follow-up of patients with sarcoidosis of varying duration Clinical and Experimental Immunology 50(1): 25-33
Szczesny, T.; Słotwiński, R.; Szczesny, G. 2005: Changes in humoral and cellular immunity in patients operated on due to esophageal cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(106): 478-482
Martín Mola, E.; Cabarcos Cazón, A.; Imizcoz, J.L.; Pérez Miranda, M. 1980: Humoral and cellular immunopathology of rheumatoid arthritis. II. Quantitative cellular immunity Revista de Medicina de la Universidad de Navarra 24(4): 43-48
Lisianyĭ, N.I.; Tsymbaliuk, V.I.; Iavorskaia, S.A.; Kurganova, L.V. 1998: Changes in the indices of cellular and humoral immunity in patients with infantile cerebral palsy Likars'ka Sprava 1998(4): 79-81
Syvolap, V.D.; Pivovar, S.N.; Syvolap, V.V. 2003: Cellular and humoral immunity in patients with acute disorder of coronary circulation Likars'ka Sprava 2003(3-4): 29-31
Rella, W.; Leber, H.; Kotz, R. 1977: Cellular immunity during and after high-dose methotrexate therapy in patients with osteosarcoma Wiener Klinische Wochenschrift 89(22): 751-755
Serebrianskaia, M.V.; Belokrinitskiĭ, D.V. 1991: The prognostic significance of cellular immunity indices in patients with peptic ulcers Laboratornoe Delo 5: 50-53